Treatment
Download 2017 CSQI Stats as PDF
CSQI 2017 Treatment Data
TREATMENT | At a Glance | Comparison Data | Most Recent Data | ||||
---|---|---|---|---|---|---|---|
Peer Review Quality Assurance for Radiation Therapy | FY2014/15 | FY2015/16 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
Percentage of completed radical courses peer reviewed by radiation oncologists | ![]() |
51.7% | 73.9% | 76.5% | 62.0% | 99.9% | 75% |
Unplanned Hospital Visits After Surgery | 2013-2014 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of patients who had breast surgery and an unplanned emergency department (ED) visit or who were readmitted within 30 days after surgery | ![]() |
NA | 17.0% | 14.4% | 10.4% | 27.3% | None |
Percentage of patients who had colorectal surgery and an unplanned emergency department (ED) visit or who were readmitted within 30 days after surgery | ![]() |
NA | 28.4% | 22.8% | 16.6% | 37.1% | None |
Percentage of patients who had prostate surgery and an unplanned emergency department (ED) visit or who were readmitted within 30 days after surgery | ![]() |
NA | 30.2% | 24.7% | 19.5% | 51.4% | None |
Percentage of patients who had thyroid surgery and an unplanned emergency department (ED) visit or who were readmitted within 30 days after surgery | ![]() |
NA | 18.5% | 12.7% | 8.3% | 20.5% | None |
Unplanned Hospital Visits During Chemotherapy | 2010-2014 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of breast cancer patients receiving New Drug Funding Program (NDFP) drugs who visited the hospital during treatment | ![]() |
NA | 55.1% | 46.0% | 32.3% | 66.9% | None |
Percentage of colon-IV cancer patients receiving New Drug Funding Program (NDFP) drugs who visited the hospital during treatment | ![]() |
NA | 55.8% | 49.2% | 35.5% | 69.8% | None |
Percentage of lymphoma patients receiving New Drug Funding Program (NDFP) drugs who visited the hospital during treatment | ![]() |
NA | 63.6% | 61.0% | 52.7% | 71.2% | None |
Percentage of colon-oral cancer patients receiving New Drug Funding Program (NDFP) drugs who visited the hospital during treatment | ![]() |
NA | 32.8% | 38.9% | 16.2% | 75.0% | None |
Reoperations after Surgery | FY2014/15-FY2015/16 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of reoperations after cancer surgeries for patients diagnosed with colon cancer | ![]() |
NA | 5.0% | 4.5% | 2.7% | 5.6% | None |
Percentage of reoperations after cancer surgeries for patients diagnosed with rectal cancer | ![]() |
NA | 3.2% | 6.0% | 3.1% | 10.0% | None |
Percentage of reoperations after cancer surgeries for patients diagnosed with prostate cancer | ![]() |
NA | 1.2% | 0.8% | 0.0% | 2.0% | None |
Team-Oriented Care for the Patient: Multidisciplinary Cancer Conferences | FY2015/16 | FY2016/17 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
Multidisciplinary cancer conference (MCC) standards concordance measure | ![]() |
94.3% | 96.3% | 88.6% | 73.3% | 98.9% | 80% |
Treating Colon Cancer According to Guidelines | 2010-2014 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of patients aged 65 and older with stage III colon cancer who received guideline-recommended chemotherapy following surgery | ![]() |
NA | 59.8% | 55.7% | 47.7% | 68.2% | None |
Percentage of stage III colon cancer patients who received adjuvant chemotherapy within 60 days of surgery | ![]() |
NA | 40.0% | 66.5% | 40.0% | 83.3% | None |
Pre-operative Staging Prior to Rectal Surgery | FY 2012/2013-FY2015/2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of patients with rectal cancer who received an MRI or TRUS in the 6 months prior to rectal cancer surgery (chemotherapy/radiation before surgery) | ![]() |
NA | 88.3% | 92.4% | 78.3% | 98.7% | None |
Percentage of patients with rectal cancer who received an MRI or TRUS in the 6 months prior to rectal cancer surgery (chemotherapy/radiation after surgery or surgery only) | ![]() |
NA | 57.4% | 67.9% | 56.2% | 87.2% | None |
Access to Psychosocial Oncology Services | 2015-2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of referred cancer patients seen within 14 days for registered dietitian services | ![]() |
NA | 93.5% | 82.4% | 50.3% | 99.3% | 85% |
Percentage of referred cancer patients seen within 14 days for social worker services | ![]() |
NA | 82.4% | 86.8% | 61.2% | 98.7% | 85% |
Wait Times for Specialist Consult for Cancer Surgery | 2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Percentage of cancer surgery patients whose surgical consult occurred within their respective Wait 1 priority access target | ![]() |
NA | 78.1% | 85.7% | 76.3% | 92.7% | 90% |
Wait Times for Cancer Surgery - Consult to Procedure | 2015 | 2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
Percentage of patients whose surgical procedure occurred within their respective Wait 2 priority access target | ![]() |
84.6% | 83.4% | 87.0% | 74.9% | 95.0% | 90% |
Access to Radiation Treatment | 2014/2015 | 2015/2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
Percentage of cancer cases treated with radiotherapy at any time in the course of their illness | ![]() |
36.9% | 38.2% | 39.0% | 30.4% | 47.0% | 48% |
Person Centred Care | FY2014/2015 | FY2015/16 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
[Composite indicator]: Percentage of positive responses to selected questions based on three dimensions of care – communication, self-management and support for shared decision-making | ![]() |
71.5% | 70.9% | 70.4% | 65.4% | 77.1% | None |
Symptom Assessment and Management | FY2013/2014 | FY2015/16 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | |
Percentage of cancer patients who were screened at least once per month for symptom severity | ![]() |
33.3% | 54.8% | 60.5% | 39.8% | 81.9% | 70% |
Patient Experience with Symptom Management | 2016 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target |
[Theme: communication] Percentage of patients who report that their healthcare team talked to them about symptoms of concern | ![]() |
NA | 74.0% | 64.0% | 52.0% | 83.0% | None |
[Theme: response to symptoms] Percentage of patients who report that their healthcare team treats and manages their physical symptoms | ![]() |
NA | 83.0% | 81.0% | 65.0% | 89.0% | None |
[Theme: response to symptoms] Percentage of patients who report that their healthcare team responds to their worries, concerns or feelings of sadness | ![]() |
NA | 79.0% | 77.0% | 65.0% | 84.0% | None |
[Theme: shared decision-making] Percentage of patients who report that their healthcare team includes them in decisions about how to treat and manage their symptoms | ![]() |
NA | 9.0% | 85.0% | 79.0% | 94.0% | None |
Wait Times from Diagnosis to Radiation Treatment | 2014-2015 | Ontario Average | Min Value in Ontario | Max Value in Ontario | Target | ||
Median wait times (in days) from diagnosis to start of treatment for oropharynx patients | ![]() |
NA | 35 | 49 | 35 | 57 | None |
Median wait times (in days) from diagnosis to start of treatment for patients with cervical cancer | ![]() |
NA | 61.5 | 61 | 33 | 75 | None |
LEGEND
|
||||||||
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
Better than Ontario Average
|
Worse than Ontario Average
|
Substantially same as Ontario Average
|
||||||
Using the most recent data year, the circles represent how the LHIN is performing compared to the Ontario average. The colours represent how well the indicator is performing against the comparison data shown. |
media inquiries
Krista DeVries
Publicity and Promotions Specialist
South West Regional Cancer Program
519-685-8500 ext. 71826
[email protected]